Literature DB >> 9722047

Ethylene glycol poisoning treated by intravenous 4-methylpyrazole.

P Hantson1, A Hassoun, P Mahieu.   

Abstract

A 19-year-old woman was admitted 45 min after ethylene glycol (EG) ingestion. The initial serum EG concentration was 1.34 g/l (21.6 mmol/l), the anion gap 14.5, and the osmolal gap 24. Renal function was preserved (serum creatinine 75.1 micromol/l). As the patient was seen soon after poisoning, before the development of metabolic acidosis, therapy with 4-methylpyrazole (4-MP) was proposed as an antidote. 4-MP was administered via the intravenous route (7 mg/kg as loading dose, followed by 3.6, 1.2, 0.6, and 0.6 mg/kg at intervals of 12 h). 4-MP alone was effective in preventing EG biotransformation to toxic metabolites (absence of metabolic acidosis and renal injury). Ethanol therapy, hemodialysis, and sodium bicarbonate administration were not required. The half-life of EG during 4-MP therapy was 11 h, with a mean EG renal clearance of 26.9 ml/min, and a total of 65.3 g EG was eliminated unchanged in the urine. 4-MP therapy was also well tolerated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9722047     DOI: 10.1007/s001340050654

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  14 in total

1.  Treatment of ethylene glycol poisoning with intravenous 4-methylpyrazole.

Authors:  F J Baud; M Galliot; A Astier; D V Bien; R Garnier; J Likforman; C Bismuth
Journal:  N Engl J Med       Date:  1988-07-14       Impact factor: 91.245

2.  Ethylene glycol intoxication. Prevention of renal failure by aggressive management.

Authors:  F Underwood; W M Bennett
Journal:  JAMA       Date:  1973-12-17       Impact factor: 56.272

3.  The effect of pyrazole on ethylene glycol toxicity and metabolism in the rat.

Authors:  J Y Chou; K E Richardson
Journal:  Toxicol Appl Pharmacol       Date:  1978-01       Impact factor: 4.219

4.  4-Methylpyrazole: a controlled study of safety in healthy human subjects after single, ascending doses.

Authors:  D Jacobsen; C S Sebastian; R Blomstrand; K E McMartin
Journal:  Alcohol Clin Exp Res       Date:  1988-08       Impact factor: 3.455

5.  4-methylpyrazole monitoring during haemodialysis of ethylene glycol intoxicated patients.

Authors:  H Faessel; P Houze; F J Baud; J M Scherrmann
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 6.  Methanol and ethylene glycol poisonings. Mechanism of toxicity, clinical course, diagnosis and treatment.

Authors:  D Jacobsen; K E McMartin
Journal:  Med Toxicol       Date:  1986 Sep-Oct

7.  Ethylene glycol poisoning. The value of glycolic acid determinations for diagnosis and treatment.

Authors:  T P Hewlett; K E McMartin; A J Lauro; F A Ragan
Journal:  J Toxicol Clin Toxicol       Date:  1986

8.  Comparison of the effects of ethanol and 4-methylpyrazole on the pharmacokinetics and toxicity of ethylene glycol in the dog.

Authors:  G F Grauer; M A Thrall; B A Henre; J J Hjelle
Journal:  Toxicol Lett       Date:  1987-02       Impact factor: 4.372

9.  Glycolate causes the acidosis in ethylene glycol poisoning and is effectively removed by hemodialysis.

Authors:  D Jacobsen; S Ovrebø; J Ostborg; O M Sejersted
Journal:  Acta Med Scand       Date:  1984
View more
  2 in total

1.  Ethylene glycol ingestion treated only with fomepizole.

Authors:  Larissa I Velez; Greene Shepherd; Yong Chan Lee; Daniel C Keyes
Journal:  J Med Toxicol       Date:  2007-09

2.  A systematic review of ethanol and fomepizole use in toxic alcohol ingestions.

Authors:  Lorri Beatty; Robert Green; Kirk Magee; Peter Zed
Journal:  Emerg Med Int       Date:  2013-01-31       Impact factor: 1.112

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.